Pharmacogenetic Allele Nomenclature: International Workgroup Recommendations for Test Result Reporting

L. V. Kalman, J. A.G. Agúndez, M. Lindqvist Appell, J. L. Black, G. C. Bell, S. Boukouvala, C. Bruckner, E. Bruford, K. Caudle, S. A. Coulthard, A. K. Daly, A. L. Del Tredici, J. T. Den Dunnen, K. Drozda, R. E. Everts, D. Flockhart, R. R. Freimuth, A. Gaedigk, H. Hachad, T. HartshorneM. Ingelman-Sundberg, T. E. Klein, V. M. Lauschke, D. R. Maglott, H. L. McLeod, G. A. McMillin, U. A. Meyer, D. J. Müller, D. A. Nickerson, W. S. Oetting, M. Pacanowski, V. M. Pratt, M. V. Relling, A. Roberts, W. S. Rubinstein, K. Sangkuhl, M. Schwab, S. A. Scott, S. C. Sim, R. K. Thirumaran, L. H. Toji, R. F. Tyndale, R. H.N. Van Schaik, M. Whirl-Carrillo, K. T.J. Yeo, U. M. Zanger

Research output: Contribution to journalArticlepeer-review

85 Scopus citations


This article provides nomenclature recommendations developed by an international workgroup to increase transparency and standardization of pharmacogenetic (PGx) result reporting. Presently, sequence variants identified by PGx tests are described using different nomenclature systems. In addition, PGx analysis may detect different sets of variants for each gene, which can affect interpretation of results. This practice has caused confusion and may thereby impede the adoption of clinical PGx testing. Standardization is critical to move PGx forward.

Original languageEnglish (US)
Pages (from-to)172-185
Number of pages14
JournalClinical pharmacology and therapeutics
Issue number2
StatePublished - Feb 1 2016

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Pharmacogenetic Allele Nomenclature: International Workgroup Recommendations for Test Result Reporting'. Together they form a unique fingerprint.

Cite this